Results 171 to 180 of about 61,737 (200)

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

, 1998
T. Poynard, P. Marcellin, Samuel S. Lee, C. Niederau, International Hepatitis Interventional Therapy Group   +4 more
semanticscholar   +1 more source

Ribavirin

Reactions Weekly, 2021
openaire   +1 more source

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

Nature Genetics, 2009
Yasuhito Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, N. Sakamoto, M. Nakagawa, M. Korenaga, K. Hino, S. Hige, Yoshito Ito, E. Mita, E. Tanaka, S. Mochida, Y. Murawaki, M. Honda, A. Sakai, Y. Hiasa, S. Nishiguchi, A. Koike, I. Sakaida, M. Imamura, Kiyoaki Ito, K. Yano, N. Masaki, F. Sugauchi, N. Izumi, K. Tokunaga, M. Mizokami   +28 more
semanticscholar   +1 more source

Ribavirin

Reactions Weekly, 2014
  +4 more sources

Ribavirin

Reactions Weekly, 2017
  +5 more sources

Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial

Nature Medicine, 2023
, Johnny Ludvigsson, Knut Dahl-Jorgensen
exaly  

Ribavirin

Reactions Weekly, 1991
openaire   +2 more sources

Ribavirin

Reactions Weekly, 2015
  +4 more sources

Ribavirin

2007
openaire   +1 more source

Ribavirin

2009
Jim Bellows, Robert Harrison, William Charney, Kevin Corkery, Lee Wugofski   +4 more
openaire   +2 more sources